Official Publications AbbVie Inc. BOERSE MUENCHEN

Equities

4AB

US00287Y1091

Market Closed - BOERSE MUENCHEN Other stock markets 15:59:44 2024-06-28 EDT			5-day change	1st Jan Change
160.3 ^EUR	+1.42%		+0.24%	+14.72%

06-28	Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	MT
06-28	AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	MT

Official Publications

SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
SEC Filing 4K	23-05-04	CO
1st quarter results	23-04-26	CO
SEC Filing 8K	23-04-26	CO
SEC Filing 4K	23-04-02	CO
SEC Filing 4K	23-04-02	CO
SEC Filing 4K	23-03-30	CO
Proxy Statments	23-03-19	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-27	CO
SEC Filing 4K	23-02-20	CO
SEC Filing 10K	23-02-16	CO
Annual results	23-02-08	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Protect and grow your investments with the help of our experts

Securing my Investments

fermer